13F

XNCR XENCOR INC

2026Q1 · CUSIP 98401F105 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
202
Δ holders QoQ
-6
Breadth percentile
Top 80%
Whale holders
116
Δ whales
0
Inst. holding value
$1.0B
New positions
26
Closed positions
32
Price momentum (1Q)
-4.2%
Put / Call
0/0

Breadth history (34 quarters)

2018Q1: Δ+16 · h=120 2018Q2: Δ+1 · h=121 2018Q3: Δ+3 · h=124 2018Q4: Δ-8 · h=116 2019Q1: Δ+3 · h=119 2019Q2: Δ-2 · h=117 2019Q3: Δ+33 · h=150 2019Q4: Δ+13 · h=163 2020Q1: Δ-18 · h=145 2020Q2: Δ+14 · h=159 2020Q3: Δ-1 · h=158 2020Q4: Δ+17 · h=175 2021Q1: Δ-3 · h=172 2021Q2: Δ+7 · h=179 2021Q3: Δ-10 · h=169 2021Q4: Δ+10 · h=179 2022Q1: Δ+2 · h=181 2022Q2: Δ-6 · h=175 2022Q3: Δ+11 · h=186 2022Q4: Δ+12 · h=198 2023Q1: Δ-10 · h=188 2023Q2: Δ-6 · h=182 2023Q3: Δ-4 · h=178 2023Q4: Δ+18 · h=196 2024Q1: Δ+6 · h=202 2024Q2: Δ-2 · h=200 2024Q3: Δ+10 · h=210 2024Q4: Δ-15 · h=195 2025Q1: Δ+8 · h=203 2025Q2: Δ-8 · h=195 2025Q3: Δ+13 · h=208 2025Q4: Δ+0 · h=208 2026Q1: Δ-6 · h=202 2018Q1: holders=120 2018Q2: holders=121 2018Q3: holders=124 2018Q4: holders=116 2019Q1: holders=119 2019Q2: holders=117 2019Q3: holders=150 2019Q4: holders=163 2020Q1: holders=145 2020Q2: holders=159 2020Q3: holders=158 2020Q4: holders=175 2021Q1: holders=172 2021Q2: holders=179 2021Q3: holders=169 2021Q4: holders=179 2022Q1: holders=181 2022Q2: holders=175 2022Q3: holders=186 2022Q4: holders=198 2023Q1: holders=188 2023Q2: holders=182 2023Q3: holders=178 2023Q4: holders=196 2024Q1: holders=202 2024Q2: holders=200 2024Q3: holders=210 2024Q4: holders=195 2025Q1: holders=203 2025Q2: holders=195 2025Q3: holders=208 2025Q4: holders=208 2026Q1: holders=202 -33 -16.5 +0 +16.5 +33 104163221 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2022Q3 Top 12% +19.4% -7.4%
2019Q3 Top 3% -0.5% -11.7%
2018Q1 Top 13% +17.4% +9.1%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-2.29
EPS YoY
Revenue (TTM)
$0.1B
Revenue YoY
-23.5%
Quarterly Revenue & EPS (4Y)
2022-06-30: $30M 2022-09-30: $27M 2022-12-31: $22M 2023-03-31: $19M 2023-06-30: $46M 2023-09-30: $59M 2023-12-31: $51M 2024-03-31: $16M 2024-06-30: $24M 2024-09-30: $18M 2024-12-31: $53M 2025-03-31: $33M 2025-06-30: $44M 2025-09-30: $21M 2025-12-31: $28M 2026-03-31: $5M 2022-06-30: EPS -0.57 2022-09-30: EPS -0.55 2022-12-31: EPS -0.20 2023-03-31: EPS -1.02 2023-06-30: EPS -0.37 2023-09-30: EPS -0.40 2023-12-31: EPS -0.41 2024-03-31: EPS -1.20 2024-06-30: EPS -1.09 2024-09-30: EPS -0.72 2024-12-31: EPS -0.57 2025-03-31: EPS -0.66 2025-06-30: EPS -0.41 2025-09-30: EPS -0.08 2025-12-31: EPS -0.09 2026-03-31: EPS -1.71 0M 30M 59M $M -1.88 -0.94 0.00 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)